Probiotic Capsule Manufacturers: Engineering Live Cultures That Survive

Table of Contents

1. Viability Beats the Number on the Label
2. Why Most Capsules Die in the Stomach
3. Capsules Win With the Right Shell
4. Moisture, Not Heat, Kills Shelf Life
5. State CFU Through End of Shelf Life
6. Five Controls a Manufacturer Must Run
7. The Verdict: Biology, Not Packaging
8. FAQ
9. References

Viability Beats the Number on the Label

A probiotic capsule is not a powder with a bacterial name on it. It is a delivery system for living cells, and those cells have to be alive : and present in sufficient count : when they arrive in the distal ileum and colon, not when they leave the factory. The benefit is strain-specific, and it is dose-specific, and it is conditional on survival. The International Scientific Association for Probiotics and Prebiotics (ISAPP) is explicit that a probiotic is defined by a genus, species and strain that confers a health benefit, and that the benefit is tied to that exact strain, not to the genus at large.

That distinction matters when you brief a manufacturer. A "10 billion CFU" label tells you the headcount on the day of bottling. It does not tell you how many cells survive gastric acid, how many survive six months on a warm shelf, or whether the strain was ever studied for the claim on the box. The job of a probiotic capsule manufacturer is to engineer the gap between those two numbers down to something you can defend on a certificate of analysis.

The category is worth getting right. The global probiotic supplements market was valued at roughly USD 8.96 billion in 2025 and is projected to reach about USD 15.66 billion by 2032, a compound annual growth rate of 8.3% (pmarketresearch, 2026). Capsules and tablets were the largest form in 2025 at 45.6% of the market. Brands are pouring into capsules precisely because the format can protect live cultures better than most : provided the manufacturer actually does the protection work.

Why Most Capsules Die in the Stomach

The first barrier is mechanical, not biological. In the fasted state, gastric pH sits around 1.5–2.0, and that acidity, plus bile salts and pancreatic enzymes lower down, inactivates unprotected cells before they reach their site of action. A live culture that is dumped into the stomach in an immediate-release shell is, functionally, a very expensive placebo by the time it clears the pylorus.

A 2024 study using the SHIME simulator of the human gut put four commercially representative formats through upper-gastrointestinal passage. The result was stark:

Source: Govaert et al., 2024, Nutrients (DOI 10.3390/nu16162791).

The difference was statistically significant (p < 0.05), and only the delayed-release format delivered enough surviving cells to shift the downstream gut microbial community toward beneficial species (Govaert et al., 2024). The takeaway for a brand is blunt: a standard capsule and a powder are nearly interchangeable at the bottom of the stomach, and neither one is doing the job the label implies.

Capsules Win With the Right Shell

Capsules are the dominant probiotic format for a reason. A shell can hold a low-moisture, precisely dosed plug of freeze-dried culture, protect it from light and oxygen, and : with the right polymer : delay opening until the intestine. The variable is which shell.

The 52-minute figure comes from a gamma-scintigraphic in vivo study commissioned by Capsugel (now Lonza), where radiolabeled unbanded delayed-release capsules resisted stomach acid and began releasing only as they left the stomach : about 45 minutes later than a typical immediate-release capsule (Lonza / Nutraceutical World, 2013). A separate 2015 study found the same acid-resistant HPMC shell gave at least a 1-log (10×) improvement in protecting probiotic viability during digestion, and showed 100% residual viability in a 24-month shelf-life test at 25 °C and at 30 °C / 13.8 and 18.2 g/m³ relative humidity (Marzorati et al., 2015, LWT).

The manufacturing implication is simple. A delayed-release vegetarian shell is the single highest-leverage choice a probiotic capsule manufacturer can make for survivability, and it does not require enteric coating, which adds cost and line time. Honglen's capsule manufacturing capability supports vegetarian and delayed-release shells, which is why our stock private label feminine pH-balance probiotic capsules and vaginal pH-balance probiotic capsules are built around protected, acid-resistant delivery rather than a bare gelatin shell.

Moisture, Not Heat, Kills Shelf Life

Heat gets blamed for dead probiotics, but the proximate cause of ambient-temperature die-off is usually water activity. Live cultures are lyophilized (freeze-dried) into a dormant state, and any free moisture in the capsule, the bottle headspace, or the pack reawakens metabolism and starts the clock. For most Lactobacillus and Bifidobacterium strains, the real enemy in distribution is a humid warehouse and a leaky closure, not a warm one.

That is why the packaging engineering matters as much as the biology:

• Blister foil (aluminium/plastic) breaks the moisture path far better than an HDPE bottle with a desiccant alone.
• Nitrogen flushing displaces oxygen from the headspace, slowing oxidation of the cell wall.
• Integrated desiccants hold the local humidity down after the pack is opened.
• Low-moisture shells help: acid-resistant HPMC carries roughly 2.5× less water than standard gelatin at ambient conditions (Marzorati et al., 2015).

A credible stability programme reflects the real destination market. For warm, humid regions, stability studies should run at 30 °C / 65% RH or higher, not just the temperate 25 °C / 60% RH baseline : the profile most stability protocols use for temperate markets. If a manufacturer only has 25 °C data, they are quoting you a product for a climate their customers do not live in.

State CFU Through End of Shelf Life

The single most abused number in the category is the CFU count. "CFU at time of manufacture" measures the headcount on bottling day, before any storage die-off. For illustration: a bottle labelled 10 billion CFU at manufacture can deliver only 1–3 billion by the end of shelf life if nobody managed the decline : which is exactly why the count must be guaranteed through expiry, not at bottling.

The honest standard, repeated by ISAPP and by FAO/WHO guidance, is to state the minimum viable count through the end of shelf life. A "live at expiry" guarantee means the manufacturer ran real-time (and accelerated) stability, modelled the die-off curve, and set the initial fill so the floor at expiry still meets claim. To build that buffer, manufacturers commonly add a 2–3× overage on the label claim : that overage is the safety margin, not a bonus dose (usefulvitamins / ISAPP synthesis, 2025).

Two consequences for a brand:

1. Ask for the expiry-date CFU, not the manufacture-date CFU. If a supplier cannot show you a stability report with enumeration at release, mid-shelf and end-of-shelf, they are guessing.
2. Match the dose to the strain, not to the competitor's label. The NIH ODS notes that studied probiotic doses commonly fall in the range of about 1 billion to 10 billion or more CFU per day, and that benefits are strain-specific : a higher number of an unstudied strain is not "stronger," it is just a higher number.

Five Controls a Manufacturer Must Run

Every serious probiotic capsule programme comes down to the same five levers. None are exotic; all of them cost development time, which is exactly why weak products exist.

1. Strain identity and documentation. Require genus, species and strain code (for example Lactobacillus rhamnosus GG, not just "a Lactobacillus"), plus deposition numbers and clinical evidence for the claim. Our women's vaginal health probiotic capsules are built around named vaginal blends at 6 Billion CFU, because the claim depends on the strain.
2. Acid-resistant delivery. Use a delayed-release or enteric shell so cultures clear the stomach. See the survival data above : this is the difference between >50% and <1%.
3. Moisture and oxygen control. Low-moisture shell, desiccated plug, nitrogen-flushed and foil-backed pack, validated for the destination climate.
4. Defensible overage from stability data. Set the initial CFU from real-time and accelerated studies, not from a rule of thumb, and guarantee it through expiry.
5. Finished-goods release testing. Enumerate total viable count (CFU) on the finished, packed capsule : not just the raw material : plus pathogen absence (Salmonella, E. coli O157:H7, S. aureus), heavy metals and mycotoxins, with batch COAs and retained samples.

Honglen runs these controls under FDA registration, cGMP, BRC, FSSC, HACCP and ISO 22000, with in-house potency and stability testing and a mandatory pre-production sample before every bulk run. Dietary supplement cGMP requirements are codified in 21 CFR Part 111. The full workflow is on our OEM and ODM services page, and moisture-barrier packaging options are covered under custom packaging.

The Verdict: Biology, Not Packaging

The brands that win in probiotics are not the ones with the biggest CFU number on the front of the box. They are the ones whose manufacturer treated the capsule as a live-organism delivery problem: named the strain, protected it through the stomach, sealed it against moisture, and proved the count at expiry with real data. The brands that lose are the ones who bought a "10 billion CFU" powder in a gel cap and called it a probiotic.

If you are commissioning a probiotic capsule, the questions above are your filter. A manufacturer that cannot answer all four is selling you a dead culture in a pretty shell.

Frequently Asked Questions

References

1. Govaert, M., Rotsaert, C., Vannieuwenhuyse, C., Duysburgh, C., Medlin, S., Marzorati, M., & Jarrett, H. (2024). Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. Nutrients, 16(16):2791. DOI: 10.3390/nu16162791
2. Marzorati, M., Possemiers, S., Verhelst, A., Cadé, D., Madit, N., & Van de Wiele, T. (2015). A novel hypromellose capsule, with acid resistance properties, permits the targeted delivery of acid-sensitive products to the intestine. LWT : Food Science and Technology, 60(1):544–551. DOI: 10.1016/j.lwt.2014.08.040
3. Lonza Capsules & Health Ingredients (2013). DRcaps acid-resistant delayed-release capsules: in vivo gamma-scintigraphic study (Bio-Images Research, Glasgow). Reported in Nutraceutical World, "Lonza's DRcaps Capsules Positioned to Help Usher in Next Generation Formulations."
4. U.S. National Institutes of Health, Office of Dietary Supplements. Probiotics : Health Professional Fact Sheet. (Typical studied doses 1–10 billion or more CFU/day; benefits strain-specific.)
5. International Scientific Association for Probiotics and Prebiotics (ISAPP). Probiotic definition and labelling guidance : minimum viable count should be stated through end of shelf life, not at manufacture.
6. FAO/WHO (2002). Guidelines for the Evaluation of Probiotics in Food : strain identification and viability-at-expiry principles.
7. pmarketresearch (2026). Worldwide Probiotic Supplements Market 2026 : 2025 value USD 8.96 B; 2032 USD 15.66 B; CAGR 8.3%; capsules & tablets 45.6% of form share in 2025.
8. U.S. Food and Drug Administration. 21 CFR Part 111 : Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.